Am. J. Respir. Crit. Care Med., Volume 158, Number 3, September 1998, 876-884

Prognostic Indicators for Blood and Marrow Transplant Patients Admitted to an Intensive Care Unit

KRISTEN J. PRICE, PETER F. THALL, SUSANNAH K. KISH, VICKIE R. SHANNON, and BORJE S. ANDERSSON

Departments of Medical Specialties, Biomathematics, Critical Care, and Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Although hematopoietic stem cell transplantation (HSCT) can be curative in patients with certain malignancies, survival is poor if the recipient becomes critically ill. This prospective study examined the outcomes of 115 consecutive HSCT patients admitted to the medical intensive care unit (MICU) of a tertiary cancer center and identified variables associated with survival. The need for endotracheal intubation and mechanical ventilation ("intubation") had a profound adverse effect on survival. Overall, 9 of 48 (18.8%) intubated patients survived compared with a survival rate of 44 of 67 (65.7%) among patients not intubated (p < 0.001). This pattern persisted for nearly all patient subgroups. Among intubated patients, those receiving peripheral blood stem cell transplant (PBSCT) had significantly better survival than bone marrow transplant (BMT) patients (8 of 26, 31% versus 1 of 22, 4%; p = 0.028). Multiple logistic regression analyses indicated that the probability a patient admitted to the MICU survived decreased significantly if the patient was intubated, had an allogeneic rather than autologous transplant, had an infection or gastrointestinal bleeding, and also decreased with higher respiratory rate, higher heart rate, longer time from transplant to MICU admission or higher bilirubin. These results may be of value in deciding which critically ill patients will benefit from intubation following major complications after HSCT transplantation.

This article has been cited by other articles:

				F. Pene, C. Aubron, E. Azoulay, F. Blot, G. Thiery, B. Raynard, B. Schlemmer, G. Nitenberg, A. Buzyn, P. Arnaud, et al. Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports J. Clin. Oncol., February 1, 2006; 24(4): 643 - 649. [Abstract] [Full Text] [PDF]

				A. O. Soubani, E. Kseibi, J. J. Bander, J. L. Klein, G. Khanchandani, H. P. Ahmed, and J. A. Guzman Outcome and Prognostic Factors of Hematopoietic Stem Cell Transplantation Recipients Admitted to a Medical ICU Chest, November 1, 2004; 126(5): 1604 - 1611. [Abstract] [Full Text] [PDF]

				R. M. Kotloff, V. N. Ahya, and S. W. Crawford Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48. [Abstract] [Full Text] [PDF]

				H. A. Hanna, I. I. Raad, B. Hackett, S. K. Wallace, K. J. Price, D. E. Coyle, and C. L. Parmley Antibiotic-Impregnated Catheters Associated With Significant Decrease in Nosocomial and Multidrug-Resistant Bacteremias in Critically Ill Patients Chest, September 1, 2003; 124(3): 1030 - 1038. [Abstract] [Full Text] [PDF]

				T. Liesching, H. Kwok, and N. S. Hill Acute Applications of Noninvasive Positive Pressure Ventilation Chest, August 1, 2003; 124(2): 699 - 713. [Abstract] [Full Text] [PDF]

				B. Afessa, A. Tefferi, M. R. Litzow, and S. G. Peters Outcome of Diffuse Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1364 - 1368. [Abstract] [Full Text] [PDF]

				A. F. Shorr and M. H. Kollef The Quick and the Dead: The Importance of Rapid Evaluation of Infiltrates in the Immunocompromised Patient Chest, July 1, 2002; 122(1): 9 - 12. [Full Text] [PDF]

				B. Y. Khassawneh, P. White Jr., E. J. Anaissie, B. Barlogie, and F. C. Hiller Outcome From Mechanical Ventilation After Autologous Peripheral Blood Stem Cell Transplantation Chest, January 1, 2002; 121(1): 185 - 188. [Abstract] [Full Text] [PDF]

				P. B. Bach, D. Schrag, D. M. Nierman, D. Horak, P. White Jr, J. W. Young, and J. S. Groeger Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation Blood, December 1, 2001; 98(12): 3234 - 3240. [Abstract] [Full Text] [PDF]

				M. B. Feinstein, M. Mokhtari, R. Ferreiro, D. E. Stover, and A. Jakubowski Fiberoptic Bronchoscopy in Allogeneic Bone Marrow Transplantation : Findings in the Era of Serum Cytomegalovirus Antigen Surveillance Chest, October 1, 2001; 120(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				J. P. KRESS, J. CHRISTENSON, A. S. POHLMAN, D. R. LINKIN, and J. B. HALL Outcomes of Critically Ill Cancer Patients in a University Hospital Setting Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1957 - 1961. [Abstract] [Full Text]

				D. J. Nichols, R. T. Maziarz, and M. T. Haupt Mechanical Ventilation in Hematopoietic Stem Cell Transplant Patients : Is There Need for Reevaluation? Chest, October 1, 1999; 116(4): 857 - 859. [Full Text] [PDF]

				A. F. Shorr, L. K. Moores, W. J. Edenfield, R. J. Christie, and T. M. Fitzpatrick Mechanical Ventilation in Hematopoietic Stem Cell Transplantation: Can We Effectively Predict Outcomes? Chest, October 1, 1999; 116(4): 1012 - 1018. [Abstract] [Full Text] [PDF]